AstraZeneca-Daiichi Sankyo’s breast cancer drug fails in late-stage trial
British-Swedish AstraZeneca and Japan's Daiichi Sankyo’s investigational drug for breast cancer failed to significantly improve the overall survival of the patients during an
British-Swedish AstraZeneca and Japan's Daiichi Sankyo’s investigational drug for breast cancer failed to significantly improve the overall survival of the patients during an
A new sensor technology designed and developed by professors and doctors at Cambridge University Hospitals may soon make hip surgery more precise and
HQ Team September 22, 2024: AstraZeneca’s Flumist, the first at-home flu vaccine, got approved by the Food and Drug Administration, enabling consumers with
Researchers at the University of Cambridge have developed a wearable ‘smart choker’ to help people communicate after speech impairments resulting from surgery or
The West Asian Hashemite Kingdom of Jordan has been designated as the first country in the world to be verified by the WHO
Denmark’s Novo Nordisk got the backing of the European Medicines Agency for its Wegovy drug to reduce heart failure in obese people.
The imperative for the global governance of artificial intelligence (AI) is “irrefutable” as its accelerating development concentrates power and wealth on a global
Vanda Pharmaceuticals Inc’s gastroparesis drug to treat a serious stomach condition was rejected by the Food and Drug Administration (FDA), which asked for
Researchers supported by the National Institutes of Health stopped a trial after they gathered sufficient evidence that an experimental drug to treat a
The US-based Biomedical Advanced Research and Development Authority will help Switzerland’s Basilea Pharmaceutica Ltd., to develop antifungals and antibacterials with an initial funding